Ayala Tamir, PhD, Publications

Tamir, A., Jordan, B., Ritter, MA., Habib, N., Lechler, RI., Foster, GR., and Lombardi, G. IFN-a2a is sufficient for promoting dendritic cell immuno-genicity. Accepted for publication in Clin. Exp. Immunol., 2005.

Madhusudan S, Tamir A, Bates N, Flanagan E, Gore ME, Barton DP, Harper P, Seckl M, Thomas H, Lemoine NR, Charnock M, Habib NA, Lechler R, Nicholls J, Pignatelli M, Ganesan TS. A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. Clin Cancer Res. 2004 May 1;10(9):2986-96.

Frasca, L., Tamir, A., Jurcevic, S., Marinari, B., Monizio, A., Sorrentino R., Carbonari, M., Piccolella, E., Lechler, RI, Lombardi, G. Tolerance Induction in indirect alloresponses by analogs of HLA-derived peptides. Transplant. Proc., 1999, 33 (1-2): 169-70.

Frasca, L., Tamir, A., Jurcevic, S., Marinari, B., Monizio, A., Sorrentino R., Carbonari, M., Piccolella, E., Lechler, RI, Lombardi, G. (2000) Peptide- analogues as a strategy to induce tolerance in T cells with indirect allospecificity Transplantation, 2000, 70 (4):631-40.